The dipeptidyl peptidase 1 (DPP-1) inhibitor cut the annualized rate of pulmonary exacerbations by around 20% compared with ...

A phase 2 trial evaluated peanut OIT in adults with peanut-allergic using real-world peanut products, employing a Simon’s minimax two-stage design with stop:go futility analysis. Participants ...

The U.S. Food and Drug Administration approved the use of Sanofi and Regeneron's blockbuster drug Dupixent for patients with ...